How should the calcium supplement dose be divided for a 36‑week gestation infant with intrauterine growth restriction?

Calcium Supplementation Dosing for 36-Week IUGR Infant

For a 36-week gestation infant with IUGR, calcium supplementation should be divided into continuous infusion when given parenterally, or 2-3 divided doses daily when given enterally, with the total daily dose ranging from 64-140 mg/kg/day (1.6-3.5 mmol/kg/day) for growing premature infants.

Parenteral Nutrition Approach

For infants requiring parenteral nutrition (PN), the ESPGHAN/ESPEN/ESPR/CSPEN 2018 guidelines provide clear dosing parameters 1:

• Growing premature infants (which includes your 36-weeker once stabilized): 1.6-3.5 mmol/kg/day (64-140 mg/kg/day) calcium
• Critical consideration for IUGR: These infants require careful monitoring of plasma phosphate concentration within the first days of life to prevent severe hypophosphataemia, which can result in muscle weakness, respiratory failure, cardiac dysfunction, and death 1

Key PN Administration Principles

Calcium in PN is given as continuous infusion, not in divided doses, as it is compounded into the PN solution 1. The division concept applies to the Ca:P ratio and timing considerations:

• During early PN (first days of life): Use lower intakes of 0.8-2.0 mmol/kg/day (32-80 mg/kg/day) 1
• Once stable and growing: Advance to 1.6-3.5 mmol/kg/day 1
• Use a molar Ca:P ratio below 1 (0.8-1.0) in early PN to reduce hypercalcaemia and hypophosphataemia risk 1
• Use organic Ca and P salts to prevent precipitation 1

Enteral Supplementation Approach

When calcium is given enterally as a supplement (not via PN), the evidence from pediatric CKD guidelines suggests practical dosing divisions 2:

• Divide into 2-3 doses daily when using calcium salts as supplements
• Calcium carbonate (40% elemental calcium) or calcium acetate (25% elemental calcium) are well-tolerated options 2
• Avoid calcium citrate in infants with potential renal issues 2
• Avoid calcium chloride due to risk of metabolic acidosis 2

Timing Considerations for Enteral Dosing

• When used as a supplement (not phosphate binder): Give between feedings to maximize absorption
• When used as a phosphate binder: Give with meals (though this is rarely the primary indication in neonates)

Critical Monitoring Requirements

For IUGR infants specifically, the guidelines emphasize 1:

• Regular monitoring of alkaline phosphatase, Ca, P, and Mg serum concentrations
• Monitor Ca and P urine concentrations
• Target simultaneous urinary excretion of both Ca and P with low concentrations (>1 mmol/L) indicating adequate surplus 1
• Phosphorus takes priority in IUGR infants—ensure adequate P provision first to prevent life-threatening hypophosphataemia 1

Common Pitfalls to Avoid

1. Do not use acidic calcium gluconate solutions in glass vials for PN—they are contaminated with aluminum 1
2. Do not use standard adult reference ranges for phosphate—preterm infants have higher lower limits (1.6 mmol/L vs 1.0 mmol/L in adults) 1
3. Do not provide high Ca:P ratios early on—this increases hypophosphataemia risk in IUGR infants with high protein needs 1
4. Do not forget to provide simultaneous phosphorus—calcium alone without adequate phosphorus will not support bone mineralization 1

Practical Summary

• PN route: Continuous infusion at 64-140 mg/kg/day once stable (lower initially)
• Enteral route: 2-3 divided doses daily using calcium carbonate or acetate
• IUGR-specific: Prioritize phosphorus adequacy and monitor closely for hypophosphataemia
• Always: Provide calcium and phosphorus simultaneously with appropriate ratio (0.8-1.0 molar ratio early, 1.3 when stable)